There is no clarity on whether a COVID-19 vaccine, whenever it is ready, will be free of cost for everyone in India and it being so would depend on the outcome of clinical trials underway to test the vaccine, said the head of the committee overseeing vaccine development as well as planning its distribution.
“We’ll have more clarity in the weeks ahead when trial data from the ongoing trials (phase 3) of the Serum Institute of India (which is testing the Oxford AstraZeneca vaccine) is available. The success of it and the other candidates will determine the availability and the dosage required and then we can discuss financing. The next three weeks will yield clarity on this,” said Dr. V.K. Paul of the NITI Aayog, who heads the Centre’s expert committee on vaccines. He was speaking on the sidelines of a press briefing on Tuesday.
At the briefing, in response to a question from The Hindu, Dr. Paul said that “for the foreseeable future” it looked like “resources wouldn’t be a problem” in making vaccines available for free. – The Hindu